Saudi Arabia Dietary Supplements Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)
Get a Comprehensive Overview of the Saudi Arabia Dietary Supplements Market Report Prepared by P&S Intelligence, Segmented by Product Type (Vitamin, Combination Dietary Supplements, Protein, Herbal Supplements, Fish Oil and Omega Fatty Acids), Form (Capsule, Tablet, Powder, Soft Gel, Liquid), Distribution Channel (Pharmacies and Drugstores, Online, Supermarkets and Hypermarkets), Application (Immunity, General Health, Energy and Weight Management, Bone and Joint Health), End User (Adults, Geriatrics, Pregnant Females, Children, Infants), and Geographic Regions. This Report Provides Insights from 2019 to 2030.
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product type
1.4.2. Market size breakdown, by form
1.4.3. Market size breakdown, by distribution channel
1.4.4. Market size breakdown, by application
1.4.5. Market size breakdown, by end user
1.4.6. Market size breakdown, by province
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Saudi Arabia Market
6.1. Overview
6.2. Market Revenue, by Product Type (2019–2030)
6.3. Market Revenue, by Form (2019–2030)
6.4. Market Revenue, by Distribution Channel (2019–2030)
6.5. Market Revenue, by Application (2019–2030)
6.6. Market Revenue, by End User (2019–2030)
6.7. Market Revenue, by Province (2019–2030)
Chapter 7. Competitive Landscape
7.1. List of Market Players and their Offerings
7.2. Competitive Benchmarking of Key Players
7.3. Product Benchmarking of Key Players
7.4. Recent Strategic Developments
Chapter 8. Company Profiles
8.1. Bayer Saudi Arabia LLC
8.1.1. Business overview
8.1.2. Product and service offerings
8.1.3. Key financial summary
8.2. Procter & Gamble Company
8.2.1. Business overview
8.2.2. Product and service offerings
8.2.3. Key financial summary
8.3. Abbott Saudi Arabia Trading LLC
8.3.1. Business overview
8.3.2. Product and service offerings
8.3.3. Key financial summary
8.4. Pfizer Saudi Limited
8.4.1. Business overview
8.4.2. Product and service offerings
8.4.3. Key financial summary
8.5. Nestlé S.A. (Al Muhaidib Group)
8.5.1. Business overview
8.5.2. Product and service offerings
8.5.3. Key financial summary
8.6. AmCan International Group
8.6.1. Business overview
8.6.2. Product and service offerings
8.6.3. Key financial summary
8.7. GSK plc
8.7.1. Business overview
8.7.2. Product and service offerings
8.7.3. Key financial summary
8.8. Archer Daniels Midland Company
8.8.1. Business overview
8.8.2. Product and service offerings
8.8.3. Key financial summary
8.9. ARKOPHARMA Laboratories Co. Ltd.
8.9.1. Business overview
8.9.2. Product and service offerings
8.9.3. Key financial summary
Chapter 9. Appendix
9.1. Abbreviations
9.2. Sources and References
9.3. Related Reports
